<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04837742</url>
  </required_header>
  <id_info>
    <org_study_id>202101007RINA</org_study_id>
    <nct_id>NCT04837742</nct_id>
  </id_info>
  <brief_title>The Effect of Ultrasound-guided Erector Spinae Plane Block on Postoperative Analgesia in Radiofrequency Ablation Therapy</brief_title>
  <official_title>The Effect of Ultrasound-guided Erector Spinae Plane Block on Postoperative Analgesia in Radiofrequency Ablation Therapy</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>National Taiwan University Hospital</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>National Taiwan University Hospital</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      This is a double blind, randomized controlled trial to evaluate the efficacy of ESPB(Erector&#xD;
      Spinae Plane Block) on postoperative analgesia in RFA( Radiofrequency Ablation therapy). We&#xD;
      will include 80 patients, and randomly assign to ESPB(Chirocaine) group and control&#xD;
      group(normal saline).We deduce Erector spinae plane block can be use as a postoperative&#xD;
      analgesic way for patients who receive radiofrequency ablation of hepatocellular carcinoma.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Computed tomography guided radiofrequency ablation of hepatocellular carcinoma(HCC) has&#xD;
      became a popular way to treat HCC. Although the wound is small and the patients can discharge&#xD;
      on the next day, they have to suffer from moderate to severe pain. Nowadays Erector spinae&#xD;
      plane block has been applied to many surgery as a postoperative analgesic strategy. We deduce&#xD;
      Erector spinae plane block can be use as a postoperative analgesic way for patients who&#xD;
      receive radiofrequency ablation of hepatocellular carcinoma. Besides, we will add contrast&#xD;
      medium to evaluate the spread area of local anesthetics.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">April 14, 2021</start_date>
  <completion_date type="Anticipated">February 2022</completion_date>
  <primary_completion_date type="Anticipated">December 2021</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Visual analogue pain scale at postoperative day one</measure>
    <time_frame>approximately 12-24 hrs</time_frame>
    <description>We will assess the pain intensity by using a 100-mm visual analogue scale at postoperative day one</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Drug spread level of erector spinae plane block</measure>
    <time_frame>approximately 2-3 hrs</time_frame>
    <description>We will assess the numbers of vertebral levels of erector spinae block drug spreading by using computed tomography</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Visual analogue pain scale at post-anesthesia care unit</measure>
    <time_frame>approximately 3 hours</time_frame>
    <description>We will assess the pain intensity by using a 100-mm visual analogue scale at post-anesthesia care unit</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Postoperative recovery quality</measure>
    <time_frame>approximately 2 days</time_frame>
    <description>We will assess the quality of recovery by using QoR-15 questionnaire at the postoperative day one</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">80</enrollment>
  <condition>Hepatocellular Carcinoma</condition>
  <arm_group>
    <arm_group_label>ESPB group</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>ESPB injection at T8 region with levobupivacaine 100mg (20 ml)+ Iohexol 10 ml</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Control group</arm_group_label>
    <arm_group_type>Sham Comparator</arm_group_type>
    <description>ESPB injection at T8 region with 0.9% normal saline 20ml + Iohexol 10ml</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>ESPB group</intervention_name>
    <description>ESPB injection at T8 region with Chirocaine 100mg(20 cc)+ Omipaque 10cc</description>
    <arm_group_label>ESPB group</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Control group</intervention_name>
    <description>ESPB injection at T8 region with Normal saline 20cc + Omnipaque 10cc</description>
    <arm_group_label>Control group</arm_group_label>
    <other_name>ESPB group</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Patients undergoing computed tomography guided radiofrequency ablation of hepatic tumor&#xD;
        under scheduled general anesthesia, and fulfilled one of following inclusion criteria:&#xD;
&#xD;
          1. diameter of hepatic tumor is larger than 2 cm&#xD;
&#xD;
          2. distance of tumor site is near the hepatic surface &lt; 2cm&#xD;
&#xD;
        Exclusion criteria:&#xD;
&#xD;
          1. A history of allergic reaction to local anesthetics or iohexol&#xD;
&#xD;
          2. Renal insufficiency, creatinine clearance &lt; 30mL/min&#xD;
&#xD;
          3. Coagulopathy or other bleeding disorder that cannot perform nerve block&#xD;
&#xD;
          4. Under pregnancy or lactation&#xD;
&#xD;
          5. Opioid tolerant patient&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>20 Years</minimum_age>
    <maximum_age>85 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Ming-Shiang Wu</last_name>
    <role>Principal Investigator</role>
    <affiliation>National Taiwan University Hospital</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Wen-Yun Niu</last_name>
    <phone>0223123456</phone>
    <email>niuwenyun@gmail.com</email>
  </overall_contact>
  <location>
    <facility>
      <name>National Taiwan University Hospital</name>
      <address>
        <city>Taipei</city>
        <zip>100</zip>
        <country>Taiwan</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Wen-Yun Niu</last_name>
      <phone>886-23123456</phone>
      <email>niuwenyun@gmail.com</email>
    </contact>
  </location>
  <location_countries>
    <country>Taiwan</country>
  </location_countries>
  <verification_date>April 2021</verification_date>
  <study_first_submitted>April 6, 2021</study_first_submitted>
  <study_first_submitted_qc>April 6, 2021</study_first_submitted_qc>
  <study_first_posted type="Actual">April 8, 2021</study_first_posted>
  <last_update_submitted>April 13, 2021</last_update_submitted>
  <last_update_submitted_qc>April 13, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">April 15, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>hepatocellular carcinoma</keyword>
  <keyword>radiofrequency ablation</keyword>
  <keyword>erector spinae plane block</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Carcinoma, Hepatocellular</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

